Prospects for the prevention of breast cancer.
Breast cancer is the most common cancer in women and is a major killer. Modern treatment has had little impact on mortality. Prevention may alter the outcome. However, women at high risk must be identified and a safe agent needs to be available. These two aspects are the subject of intensive investigation and are discussed in this chapter.
Fentiman
I S
IS
ICRF Clinical Oncology Unit, Guy's Hospital, London, England.
D001943:Breast Neoplasms / Q000209:etiology / Q000517:prevention & control*; D015331:Cohort Studies; D003131:Combined Modality Therapy; D004041:Dietary Fats / Q000009:adverse effects; D005260:Female; D006801:Humans; D009376:Neoplasms, Hormone-Dependent / Q000517:prevention & control; D012307:Risk Factors; D013629:Tamoxifen / Q000008:administration & dosage / Q000009:adverse effects
D004041:Dietary Fats; D013629:Tamoxifen